Pearl Diagnostics, Inc.

Biotech Baltimore, MD

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Baltimore, MD
Street
1812 Ashland Avenue
Zip
21205

Offering

Total offering
$11.2M
Amount sold
$11.2M
First sale
Mar 19, 2026
Min investment
$57k
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
21

How this filing compares

Ranked #9 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 3.7× the median.

Other Maryland filings this week: Synergy Cypress LLC, Peachtree Co-Invest, L.P.

Leadership

Kieren Marr — Executive Officer (also: Director)

Brad Spellberg — Director

John Cammack — Director

Eric Gornstein — Executive Officer (also: Director)

Filing details

Pearl Diagnostics, Inc. filed a Form D with the SEC on April 21, 2026.

Other newest Biotech companies

Other newest companies in Maryland